317 related articles for article (PubMed ID: 23314013)
1. Self-care and communication issues at the end of life of recipients of a left-ventricular assist device as destination therapy.
Ben Gal T; Jaarsma T
Curr Opin Support Palliat Care; 2013 Mar; 7(1):29-35. PubMed ID: 23314013
[TBL] [Abstract][Full Text] [Related]
2. Perceptions of Bereaved Caregivers and Clinicians About End-of-Life Care for Patients With Destination Therapy Left Ventricular Assist Devices.
Chuzi S; Ogunseitan A; Cameron KA; Grady K; Schulze L; Wilcox JE
J Am Heart Assoc; 2021 Aug; 10(15):e020949. PubMed ID: 34308687
[TBL] [Abstract][Full Text] [Related]
3. End-of-life decision making and implementation in recipients of a destination left ventricular assist device.
Brush S; Budge D; Alharethi R; McCormick AJ; MacPherson JE; Reid BB; Ledford ID; Smith HK; Stoker S; Clayson SE; Doty JR; Caine WT; Drakos S; Kfoury AG
J Heart Lung Transplant; 2010 Dec; 29(12):1337-41. PubMed ID: 20817564
[TBL] [Abstract][Full Text] [Related]
4. Ethical challenges in advanced heart failure.
Kini V; Kirkpatrick JN
Curr Opin Support Palliat Care; 2013 Mar; 7(1):21-8. PubMed ID: 23328735
[TBL] [Abstract][Full Text] [Related]
5. The use of advance directives among patients with left ventricular assist devices.
Swetz KM; Mueller PS; Ottenberg AL; Dib C; Freeman MR; Sulmasy DP
Hosp Pract (1995); 2011 Feb; 39(1):78-84. PubMed ID: 21441762
[TBL] [Abstract][Full Text] [Related]
6. Destination Therapy: Standardizing the Role of Palliative Medicine and Delineating the DT-LVAD Journey.
Woodburn JL; Staley LL; Wordingham SE; Spadafore J; Boldea E; Williamson S; Hollenbach S; Ross HM; Steidley DE; Pajaro OE
J Pain Symptom Manage; 2019 Feb; 57(2):330-340.e4. PubMed ID: 30447385
[TBL] [Abstract][Full Text] [Related]
7. Palliative care and end-of-life issues in patients treated with left ventricular assist devices as destination therapy.
Swetz KM; Ottenberg AL; Freeman MR; Mueller PS
Curr Heart Fail Rep; 2011 Sep; 8(3):212-8. PubMed ID: 21538039
[TBL] [Abstract][Full Text] [Related]
8. Upstream palliative care for the patient with a left ventricular assist device as destination therapy.
Byram EK
Dimens Crit Care Nurs; 2012; 31(1):18-24. PubMed ID: 22156807
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study.
Warraich HJ; Allen LA; Blue LJ; Chaussee EL; Thompson JS; McIlvennan CK; Flint KM; Matlock DD; Patel CB
Am Heart J; 2019 Jul; 213():91-96. PubMed ID: 31129442
[TBL] [Abstract][Full Text] [Related]
10. End-of-life care in the treatment of advanced heart failure in the elderly.
McClung JA
Cardiol Rev; 2013; 21(1):9-15. PubMed ID: 22874884
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
[TBL] [Abstract][Full Text] [Related]
12. A call for guidance in the use of left ventricular assist devices in older adults.
Vitale CA; Chandekar R; Rodgers PE; Pagani FD; Malani PN
J Am Geriatr Soc; 2012 Jan; 60(1):145-50. PubMed ID: 22239293
[TBL] [Abstract][Full Text] [Related]
13. Ethical challenges with the left ventricular assist device as a destination therapy.
Rizzieri AG; Verheijde JL; Rady MY; McGregor JL
Philos Ethics Humanit Med; 2008 Aug; 3():20. PubMed ID: 18694496
[TBL] [Abstract][Full Text] [Related]
14. Improving end-of-life care for ventricular assist devices (VAD) patients: paradox or protocol?*.
McGonigal P
Omega (Westport); 2013; 67(1-2):161-6. PubMed ID: 23977792
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
16. Matters to address prior to introducing new life support technology in Japan: three serious ethical concerns related to the use of left ventricular assist devices as destination therapy and suggested policies to deal with them.
Asai A; Masaki S; Okita T; Enzo A; Kadooka Y
BMC Med Ethics; 2018 Feb; 19(1):12. PubMed ID: 29482542
[TBL] [Abstract][Full Text] [Related]
17. Sex and intimacy among patients with implantable left-ventricular assist devices.
Marcuccilli L; Casida JJ; Peters RM; Wright S
J Cardiovasc Nurs; 2011; 26(6):504-11. PubMed ID: 21372729
[TBL] [Abstract][Full Text] [Related]
18. To explore the prevalence and outcomes of advance care planning for patients with left ventricular assist devices: A review.
Delmaczynska E; Newham R
J Clin Nurs; 2019 May; 28(9-10):1365-1379. PubMed ID: 30552798
[TBL] [Abstract][Full Text] [Related]
19. [Advance directives in palliative care units].
Déramé L; Paillet D; Pautex S
Rev Med Suisse; 2008 Feb; 4(145):467-9. PubMed ID: 18376523
[TBL] [Abstract][Full Text] [Related]
20. Cardiology patient pages: ventricular assist devices: important information for patients and families.
Givertz MM
Circulation; 2011 Sep; 124(12):e305-11. PubMed ID: 21931095
[No Abstract] [Full Text] [Related]
[Next] [New Search]
